STOCK TITAN

MicroVision Announces Pricing of $17.0 Million Public Offering

MicroVision (NASDAQ:MVIS) has priced a public offering of 6,800,000 units at $2.50 per unit, each unit consisting of one common share and one warrant to purchase one share.

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags

MicroVision (NASDAQ:MVIS) has priced a public offering of 6,800,000 units at $2.50 per unit, each unit consisting of one common share and one warrant to purchase one share. Warrants are immediately exercisable at $2.50 and expire five years from issuance.

Gross proceeds are expected to be approximately $17.0 million, before fees and expenses. According to MicroVision, net proceeds will be used for general corporate purposes, including working capital and capital expenditures. WestPark Capital is exclusive placement agent, and the offering is expected to close on or around August 17, 2026, under an effective SEC Form S-3 registration.

Loading...
Loading translation...

Positive

  • $17.0 million expected gross proceeds from the public offering
  • Immediate-exercise five-year warrants at $2.50 potentially add future capital
  • Use of proceeds for working capital and capital expenditures

Negative

  • Issuance of 6,800,000 new shares plus matching warrants may dilute existing shareholders

News Explained

If completed, the offering can reduce existing ownership through new common and warrant shares; gross proceeds equal 80.8 days of Q2 operating cash use.

MicroVision has priced, but not closed, an offering that would issue 6,800,000 common shares and warrants exercisable for one additional share per unit; issuing those additional shares would reduce existing holders’ percentage ownership absent offsetting changes.

The effective Form S-3 provides registration capacity rather than completing a sale; the release sets terms for this offering, while closing remains expected around August 17, 2026.

Using second-quarter 2026 operating cash outflow as a historical comparison, the offering’s $17.0 million gross proceeds equal 80.8 days of that cash use before fees and expenses.

The named milestone is closing on or around August 17, 2026; until then, the proceeds and securities remain announced terms rather than completed financing.

Sources and calculations
  • Offering gross against the last reported quarterly operating outflow, in days at that rate $17,000,000 / ($19,145,000 / 91) = 80.8 days
Argus Aug 14 session 89 alerts
-40.85% close to close 73.9x rel. volume Open Argus
Details

Market move: MVIS -40.85% in the Aug 14 session. public offering pricing

-37.6% Trough in 5 hr 27 min
$92.13M Market Cap

On Aug 14, the day this news came out, MVIS closed 40.85% below the previous close. Argus tracked a trough of -37.6% from its starting point during tracking. Our momentum scanner recorded 89 alerts for this stock that day. Relative volume reached 73.9x the daily average during tracking.

Data tracked by StockTitan Argus for the Aug 14 session.

Key Figures

Offering units: 6,800,000 units Offering price: $2.50 per unit Warrant exercise price: $2.50 per share +4 more
Offering units
6,800,000 units
Public offering
Offering price
$2.50 per unit
Public offering
Warrant exercise price
$2.50 per share
Immediately exercisable warrants
Warrant term
Five years
Expiration from issuance
Gross proceeds
$17.0 million
Before fees and offering expenses
Expected closing
August 17, 2026
Offering close
S-3 effectiveness date
July 15, 2026
Registration statement declared effective by the SEC

Historical Context

5 past events · Latest: Aug 10
5 events
  1. Aug 10

    CFO appointment

    24h Move
    +9.9%

    CFO appointment with effective date and finance leadership transition

  2. Aug 06

    Q2 earnings report

    24h Move
    +3.8%

    Q2 revenue growth accompanied by larger net loss and commercial updates

  3. Aug 05

    Product launch

    24h Move
    -13.1%

    MOVIA Air launch expanded lidar applications into aerospace, defense, and drone markets

  4. Jul 28

    Earnings scheduling

    24h Move
    -2.5%

    Scheduled Q2 results release and investor conference call

  5. Jul 22

    Reverse stock split

    24h Move
    -11.8%

    Reverse split aimed at supporting Nasdaq minimum bid compliance

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

warrant, placement agent, form s-3, registration statement
4 terms
warrant financial
"one share of common stock and (ii) one warrant to purchase one share"
A warrant is a time-limited financial contract that gives its holder the right to buy a company's shares at a set price before a specified date, like a coupon that lets you purchase stock at a fixed discount for a limited time. It matters to investors because warrants offer leveraged exposure to a stock’s upside and can dilute existing shareholders if exercised, so they affect potential gains and the company’s outstanding share count.
placement agent financial
"WestPark Capital, Inc. is acting as exclusive placement agent"
A placement agent is a professional or firm that helps organizations raise money from investors, such as individuals, institutions, or funds. They act like matchmakers, connecting those seeking investments with the right investors and guiding the process to ensure successful funding. For investors, they can provide access to exclusive opportunities and help navigate complex fundraising efforts.
form s-3 regulatory
"being offered pursuant to a registration statement on Form S-3"
Form S-3 is a legal document companies use to register their stock sales with the government, making it easier and faster for them to raise money by selling shares to investors. It’s like having a pre-approved shopping list that lets a company quickly sell new shares when they need funds, without going through a lengthy approval process each time.
registration statement regulatory
"pursuant to a registration statement on Form S-3"
A registration statement is a formal document that companies file with a government agency to offer new shares of stock to the public. It provides essential information about the company's finances, operations, and risks, helping investors make informed decisions. Think of it as a detailed product description that ensures transparency and trust before buying into a company.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

REDMOND, WA / ACCESS Newswire / August 14, 2026 / MicroVision, Inc. (NASDAQ:MVIS) ("MicroVision" or "Company"), a leader in advanced perception solutions for industrial, security and defense, and automotive applications, today announced the pricing of its public offering of an aggregate of 6,800,000 units, at a public offering price of $2.50 per unit, consisting of (i) one share of common stock and (ii) one warrant to purchase one share of common stock, immediately exercisable at a price of $2.50 per share and expiring five years from the date of issuance.

The gross proceeds from the offering, before deducting the placement agent's fees and other offering expenses, are expected to be approximately $17.0 million. MicroVision expects to use the net proceeds from the offering for general corporate purposes, including working capital and capital expenditures.

WestPark Capital, Inc. is acting as exclusive placement agent for the offering. The offering is expected to close on or around August 17, 2026.

The securities described above are being offered pursuant to a registration statement on Form S-3 (File No. 333-297430), which was declared effective by the Securities and Exchange Commission (the "SEC") on July 15, 2026. The offering is being made only by means of a prospectus which is a part of the effective registration statement. A preliminary prospectus related to the offering has been filed with the SEC. Copies of the final prospectus, when available, will be filed with the SEC and may be obtained from WestPark Capital, Inc., 1800 Century Park East, Suite 220, Los Angeles, California 90067. Electronic copies of the preliminary prospectus supplement and accompanying prospectus will also be available on the website of the SEC at http://www.sec.gov.

Disclosures

This press release shall not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of any securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About MicroVision

MicroVision is defining the next generation of lidar-based perception solutions for industrial, security & defense, and automotive markets. As the industry moves beyond proof of concept toward value, deployment, and commercialization, MicroVision delivers integrated hardware and software solutions designed for real-world performance, automotive-grade reliability, and economic scalability. With engineering centers in the U.S. and Germany, MicroVision leads the industry in depth and breadth of its portfolio, with both short- and long-range lidar solutions, featuring solid-state sensors with varying wavelengths, advanced sensor architectures, design-to-cost engineering, and open software solutions.

MicroVision, MOSAIK, MOVIA, IRIS, and SENTINEL are trademarks of MicroVision, Inc. in the United States and other countries. All other trademarks are the properties of their respective owners.

Forward-Looking Statements

Certain statements contained in this release, including statements relating to conducting the offering, the completion of the offering or use of proceeds, the ability to satisfy closing conditions related to the offering and the overall timing and completion of such closing, and expectations for increases or decreases in expenses and are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those projected in such forward-looking statements include the risk of MicroVision's ability to operate with limited cash or to raise additional capital when needed; market acceptance of its technologies and products; the failure of its commercial partners to perform as expected under its agreements; its financial and technical resources relative to those of its competitors; its ability to keep up with rapid technological change; government regulation of its technologies; its ability to enforce its intellectual property rights and protect its proprietary technologies; the ability to obtain customers and develop partnership opportunities; the timing of commercial product launches and delays in product development; the ability to achieve key technical milestones in key products; dependence on third parties to develop, manufacture, sell and market its products; potential product liability claims; its ability to maintain its listing on The Nasdaq Stock Market, and other risk factors identified from time to time in the Company's SEC reports, including the Company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed with the SEC. These factors are not intended to represent a complete list of the general or specific factors that may affect the Company. It should be recognized that other factors, including general economic factors and business strategies, may be significant, now or in the future, and the factors set forth in this release may affect the Company to a greater extent than indicated. Except as expressly required by federal securities laws, the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in circumstances or any other reason.

Investor Relations Contact

Jeff Christensen
Darrow Associates Investor Relations
MVIS@darrowir.com

Media Contact

Heidi Davidson
heidi@galvanizeworldwide.com
(914) 441-6862

SOURCE: MicroVision, Inc.



View the original press release on ACCESS Newswire

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What are the key terms of MicroVision (NASDAQ:MVIS) $17 million public offering announced on August 14, 2026?

MicroVision priced 6,800,000 units at $2.50 per unit, each containing one share and one warrant. According to MicroVision, warrants are immediately exercisable at $2.50 per share and expire five years from the date of issuance.

How many shares and warrants are included in MicroVision’s August 2026 MVIS public offering?

The offering includes 6,800,000 units, each with one common share and one warrant, for 6,800,000 shares and 6,800,000 warrants. According to MicroVision, every warrant allows purchase of one share at $2.50 for five years.

How much money will MicroVision (MVIS) raise from its August 2026 public offering and how will it be used?

MicroVision expects gross proceeds of approximately $17.0 million from the offering, before fees and expenses. According to MicroVision, net proceeds will fund general corporate purposes, including working capital needs and capital expenditure projects.

When is MicroVision’s (NASDAQ:MVIS) August 2026 public offering expected to close?

The offering is expected to close on or around August 17, 2026, subject to customary conditions. According to MicroVision, WestPark Capital is acting as exclusive placement agent for this transaction under an effective SEC Form S-3 registration.

What are the details of the warrants in MicroVision’s August 2026 MVIS unit offering?

Each unit includes one warrant to buy one common share at an exercise price of $2.50. According to MicroVision, the warrants are immediately exercisable upon issuance and will expire five years from their issue date.

How can investors access the prospectus for MicroVision’s (MVIS) August 2026 public offering?

According to MicroVision, the offering uses an effective Form S-3 registration, with a preliminary prospectus filed with the SEC. Final prospectus copies will be available from WestPark Capital and electronically via the SEC’s website at www.sec.gov.

Keep reading